XML 15 R4.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenues:        
Total net product sales $ 169,411 $ 135,590 $ 327,402 $ 254,617
Operating expenses:        
Cost of goods sold 50,627 35,248 86,701 66,597
Research and development 26,282 12,573 47,887 28,453
Selling, general and administrative 65,003 50,813 129,263 99,335
Amortization of acquired intangible assets 14,322 1,967 28,644 3,933
Acquisition-related (gains) charges, product discontinuation and other (18,058) 146 (13,721) 2,019
Total operating expenses 138,176 100,747 278,774 200,337
Income from operations 31,235 34,843 48,628 54,280
Other (expense) income:        
Interest income 252 224 523 639
Interest expense (8,833) (7,023) (19,079) (13,994)
Other, net (647) (2,396) (771) (2,554)
Total other expense, net (9,228) (9,195) (19,327) (15,909)
Income before income taxes 22,007 25,648 29,301 38,371
Income tax expense (2,131) (6,567) (2,597) (8,921)
Net income $ 19,876 $ 19,081 $ 26,704 $ 29,450
Net income per share:        
Basic net income per common share (in USD per share) $ 0.44 $ 0.43 $ 0.59 $ 0.67
Diluted net income per common share (in USD per share) $ 0.40 $ 0.42 $ 0.55 $ 0.64
Weighted average common shares outstanding:        
Basic (in shares) 45,501 44,145 45,185 43,989
Diluted (in shares) 52,478 45,592 52,262 45,779
Net product sales        
Revenues:        
Total net product sales $ 168,581 $ 134,863 $ 326,003 $ 253,601
Royalty revenue        
Revenues:        
Total net product sales 830 602 1,399 891
Collaborative licensing and milestone revenue        
Revenues:        
Total net product sales $ 0 $ 125 $ 0 $ 125